Ghemaxan

Ghemaxan is an anticoagulant medication containing Enoxaparin Sodium, used to prevent and treat blood clots. It is suitable for haemodialysis, intraarterial, and intravenous use.

Ghemaxan is primarily used to prevent and treat blood clots in various medical conditions. It is often administered during haemodialysis to maintain blood flow and prevent clotting in the dialysis circuit. Additionally, it can be used intraarterially or intravenously to manage clotting risks in other procedures.

Ghemaxan works by thinning the blood, which helps to prevent the formation of blood clots. Common effects may include bruising or bleeding at the injection site. Some users may experience mild discomfort or swelling.

Ghemaxan should be handled with care to avoid accidental injury. It is important to follow the prescribed administration guidelines to minimize the risk of bleeding. Patients with a history of bleeding disorders or allergies to heparin should consult their healthcare provider before use.

Ghemaxan may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be moderated as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking.